George Hill
Stock Analyst at Deutsche Bank
(2.93)
# 1,631
Out of 4,983 analysts
183
Total ratings
53.57%
Success rate
5.86%
Average return
Main Sectors:
Stocks Rated by George Hill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $98 → $115 | $91.54 | +25.63% | 18 | Jun 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Buy | $521 → $362 | $339.78 | +6.54% | 22 | May 14, 2025 | |
| CVS CVS Health | Upgrades: Buy | $66 | $73.48 | -10.18% | 5 | Dec 3, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $23 → $27 | $50.89 | -46.94% | 4 | Nov 6, 2024 | |
| CI The Cigna Group | Maintains: Buy | $398 → $394 | $294.21 | +33.92% | 10 | Nov 4, 2024 | |
| CAH Cardinal Health | Maintains: Hold | $119 → $124 | $148.37 | -16.43% | 12 | Nov 4, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $12 | $7.87 | +52.48% | 18 | Nov 1, 2024 | |
| HUM Humana | Maintains: Hold | $349 → $250 | $272.32 | -8.20% | 11 | Oct 3, 2024 | |
| MCK McKesson | Maintains: Buy | $623 → $579 | $693.45 | -16.50% | 7 | Sep 25, 2024 | |
| EHTH eHealth | Maintains: Hold | $5 → $2 | $3.95 | -49.37% | 14 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $38.25 | -18.95% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 → $5 | $4.09 | +22.25% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $4 | $1.12 | +257.14% | 14 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $82 → $87 | $31.80 | +173.58% | 10 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $353 | $176.45 | +100.06% | 9 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $461 → $471 | $345.19 | +36.45% | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $8 | $4.23 | +89.13% | 5 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $581 → $571 | $310.00 | +84.19% | 2 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $250 | $186.81 | +33.83% | 4 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $287 → $235 | $173.13 | +35.74% | 5 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $334 | $151.60 | +120.32% | 5 | Feb 18, 2021 |
HealthEquity
Jun 5, 2025
Maintains: Buy
Price Target: $98 → $115
Current: $91.54
Upside: +25.63%
UnitedHealth Group
May 14, 2025
Maintains: Buy
Price Target: $521 → $362
Current: $339.78
Upside: +6.54%
CVS Health
Dec 3, 2024
Upgrades: Buy
Price Target: $66
Current: $73.48
Upside: -10.18%
Hims & Hers Health
Nov 6, 2024
Maintains: Hold
Price Target: $23 → $27
Current: $50.89
Upside: -46.94%
The Cigna Group
Nov 4, 2024
Maintains: Buy
Price Target: $398 → $394
Current: $294.21
Upside: +33.92%
Cardinal Health
Nov 4, 2024
Maintains: Hold
Price Target: $119 → $124
Current: $148.37
Upside: -16.43%
Teladoc Health
Nov 1, 2024
Maintains: Hold
Price Target: $10 → $12
Current: $7.87
Upside: +52.48%
Humana
Oct 3, 2024
Maintains: Hold
Price Target: $349 → $250
Current: $272.32
Upside: -8.20%
McKesson
Sep 25, 2024
Maintains: Buy
Price Target: $623 → $579
Current: $693.45
Upside: -16.50%
eHealth
Aug 14, 2024
Maintains: Hold
Price Target: $5 → $2
Current: $3.95
Upside: -49.37%
Aug 14, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $38.25
Upside: -18.95%
Aug 9, 2024
Maintains: Hold
Price Target: $7 → $5
Current: $4.09
Upside: +22.25%
Aug 9, 2024
Maintains: Hold
Price Target: $5 → $4
Current: $1.12
Upside: +257.14%
Aug 2, 2024
Maintains: Hold
Price Target: $82 → $87
Current: $31.80
Upside: +173.58%
Jul 29, 2024
Maintains: Hold
Price Target: $354 → $353
Current: $176.45
Upside: +100.06%
Sep 5, 2023
Maintains: Buy
Price Target: $461 → $471
Current: $345.19
Upside: +36.45%
Aug 10, 2023
Maintains: Hold
Price Target: $6 → $8
Current: $4.23
Upside: +89.13%
Mar 8, 2023
Maintains: Buy
Price Target: $581 → $571
Current: $310.00
Upside: +84.19%
Mar 23, 2022
Maintains: Buy
Price Target: $255 → $250
Current: $186.81
Upside: +33.83%
Feb 25, 2022
Maintains: Hold
Price Target: $287 → $235
Current: $173.13
Upside: +35.74%
Feb 18, 2021
Maintains: Buy
Price Target: $250 → $334
Current: $151.60
Upside: +120.32%